About Warner Chilcott
Warner Chilcott is a Healthcare company based in Rockaway (United States) founded in 1999, and was acquired by Actavis in May 2013. Contract research, development, and manufacturing for biologic drugs are offered. Its chief executive, as recorded, is Rodger Boissonneault. Its focus areas include Biopharma Outsourcing, Diversified and Biologics. Its competitors include Catalent, Surrozen and Curia; 1 of its 3 listed competitors has raised funding.
Company details
Warner Chilcott was founded in 1999 and is headquartered in Rockaway, United States. Services in contract research, development, and manufacturing are provided for biologic drugs within the pharmaceutical sector. Operations focus on supporting clients through end-to-end processes for biologic products, with emphasis on regulatory compliance and quality standards in the biotechnology industry.
- InvestorsBain Capital Private Equity
& 3 more
- Acquired by
Investors in Warner Chilcott
Warner Chilcott has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Bain Capital Private Equity, Actavis and Thomas H Lee Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private investment firm managing assets and expanding into equity, credit, and real estate services. | 1984 | baincapitalprivateequity.com | London, United Kingdom | |
Private equity investments are directed toward traditional industries. | 1974 | thl.com | Boston, United States | |
Private equity investments are directed toward multiple sectors. | ccmpcapital.com | New York, United States | ||
Manufacturer of generic products | 1956 | actavis.com | Parsippany Troy Hills, United States |
Investor details for Warner Chilcott
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Warner Chilcott
1 people are tracked at Warner Chilcott (1 in leadership).
| Name | Role | Group |
|---|---|---|
Rodger Boissonneault | CEO | Leadership |
Complete people profiles for Warner Chilcott
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Warner Chilcott
3 dated milestones of Warner Chilcott across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Warner Chilcott is founded.
- Exit Acquired by CCMP Capital.
- Exit Acquired by Actavis.
Competitors of Warner Chilcott
Warner Chilcott has 3 listed competitors in our database, 1 of them funded. They include Catalent, Surrozen and Curia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| catalent.com | 2007 | Somerset, United States | 9,390 | CDMO offering drug and biologics development services | ||
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| curiaglobal.com | 1991 | Albany, United States | 1,918 | Drug research, development, testing, and consulting services are provided. |
Detailed competitors of Warner Chilcott
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Warner Chilcott (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Warner Chilcott
Complete news archive for Warner Chilcott
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Warner Chilcott
Warner Chilcott was founded in 1999.
Warner Chilcott is headquartered in Rockaway, United States. It is registered at Rockaway, New Jersey, United States.
Rodger Boissonneault is the CEO of Warner Chilcott, as recorded in our data.
Warner Chilcott was founded in 1999 and is headquartered in Rockaway, United States. Services in contract research, development, and manufacturing are provided for biologic drugs within the pharmaceutical sector. Operations focus on supporting clients through end-to-end processes for biologic products, with emphasis on regulatory compliance and quality standards in the biotechnology industry.
Warner Chilcott has 4 investors. Key investors include Bain Capital Private Equity, Actavis, Thomas H Lee Partners, and CCMP Capital.
Yes. Warner Chilcott was acquired by Actavis in May 2013.

